DR. BRIAN B. BRUGGEMAN, MD

WILKES BARRE, PA

Research Active
Plastic Surgery NPI registered 21+ years 16 publications 2000 – 2026 NPI: 1356344626
Diabetes Mellitus, Type 1Blood GlucoseSARS-CoV-2COVID-19PregnancyAntilymphocyte SerumQuality of LifeAutomobile DrivingExtracorporeal Membrane OxygenationGlycated HemoglobinC-PeptideHypoglycemic AgentsBlood Glucose Self-MonitoringAge FactorsPeripartum Period

Practice Location

675 BALTIMORE DR
WILKES BARRE, PA 18702-7900

Phone: (570) 808-6400

What does BRIAN BRUGGEMAN research?

Dr. Bruggeman studies various aspects of diabetes management and women's health, particularly how conditions like type 1 diabetes and cervical cancer can impact patients' lives. He aims to enhance patient education and engagement, especially for those at a higher risk for serious health issues. His research includes examining new treatments for type 1 diabetes, such as ultra-rapid insulin and strategies to delay disease progression in children. Additionally, he looks into how health education materials can empower women to take charge of their health, particularly regarding cervical cancer screenings.

Key findings

  • In a study on ultra-rapid lispro insulin for type 1 diabetes, only 1.7% of participants experienced severe low blood sugar, showing that the treatment is safe and effective.
  • Three out of six children who received low-dose antithymocyte globulin (ATG) were able to stay diabetes-free for 1.5 to 4 years, indicating potential in delaying disease progression.
  • The research on barriers to retinopathy screening found that 41.7% of young adults with type 1 diabetes faced significant challenges in getting necessary eye exams.

Frequently asked questions

Does Dr. Bruggeman study diabetes?
Yes, Dr. Bruggeman conducts extensive research on diabetes, focusing on type 1 diabetes management, innovative treatments, and health disparities affecting patients.
What treatments has Dr. Bruggeman researched?
He has researched treatments including ultra-rapid insulin for type 1 diabetes and low-dose antithymocyte globulin (ATG) for children to help delay diabetes progression.
Is Dr. Bruggeman's work relevant to pregnant women?
Yes, he has reviewed the use of ECMO, a life-support technique, for pregnant patients during severe health crises, emphasizing the importance of specialized care.

Publications in plain English

Risk of intracranial meningioma requiring surgical intervention among recent hormonal contraceptives users.

2026

Journal of neuro-oncology

Chen S, Jugl S, Jackson L, Rahman M, Antonelli PJ +2 more

PubMed

ECMO for the pregnant and peripartum patient: A practical review of indications, unique management considerations, and an approach framework.

2025

Perfusion

Hrymak CS, Labib A, Akkanti B, Antonini MV, Bruggeman B +10 more

Plain English
This study reviews the use of a life-support technique called extracorporeal membrane oxygenation (ECMO) for pregnant women facing severe health issues. It highlights the need for careful teamwork among medical experts, especially since the use of ECMO in pregnant patients is rare but crucial, particularly during challenging times like the COVID pandemic. The research indicates that while complications can be high-risk, pregnant patients who receive ECMO generally have better outcomes compared to non-pregnant patients. Who this helps: This benefits pregnant patients in critical condition and their healthcare providers.

PubMed

Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer.

2025

Cancer management and research

Mkuu RS, Tohme S, Rivero-Mendoza D, Salloum RG, Goede D +11 more

Plain English
This study looked at how to make educational materials about HPV self-collection tests better for women at higher risk of cervical cancer. Researchers talked to 13 women in Florida who face challenges like poverty and chronic health conditions. They found that improving the materials by using simple language, adding visual aids, and providing clearer instructions could help women feel more confident in doing self-collection tests, which may lead to more women getting screened for cervical cancer. Who this helps: This benefits women at high risk of cervical cancer by empowering them to participate in their own health care.

PubMed

Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes.

2024

Diabetes technology & therapeutics

Levy CJ, Bailey R, Laffel LM, Forlenza G, DiMeglio LA +17 more

Plain English
This study looked at how safe and effective ultra-rapid lispro insulin (URLi) is when used with the Tandem t:slim X2 insulin pump in people of all ages with type 1 diabetes. It involved 179 participants over 13 weeks, and only 1.7% experienced severe low blood sugar, while there were no cases of serious diabetic complications. Overall, participants reported significant improvements in their ability to manage blood sugar levels and their satisfaction with insulin treatment. Who this helps: This benefits individuals with type 1 diabetes and their healthcare providers.

PubMed

Diabetes and Driving: A Statement of the American Diabetes Association.

2024

Diabetes care

Cox DJ, Frier BM, Bruggeman B, Durrani T, ElSayed NA +6 more

Plain English
This paper examines how diabetes affects a person's ability to drive and the rules around getting a driver's license for those with the condition. It found that simply having diabetes does not automatically mean someone is a bad driver; instead, various factors should be considered when assessing a person's driving skills. This is important because it ensures drivers with diabetes can fairly maintain their independence while also being safe on the road. Who this helps: Patients with diabetes and their healthcare providers.

PubMed

Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes.

2024

Diabetes care

Foster TP, Jacobsen LM, Bruggeman B, Salmon C, Hosford J +9 more

Plain English
This study looked at how well low-dose antithymocyte globulin (ATG) works in treating children with early stage 2 type 1 diabetes. Out of six children, three remained free of diabetes for up to four years after treatment, while the other three moved to a more severe stage of diabetes shortly after. Remarkably, even those who progressed showed near-normal blood sugar levels and low insulin needs after 18 months, indicating that ATG may help manage diabetes symptoms. Who this helps: This helps children with early stage 2 type 1 diabetes.

PubMed

Evaluating professional development for blended learning in higher education: a synthesis of qualitative evidence.

2022

Education and information technologies

Garone A, Bruggeman B, Philipsen B, Pynoo B, Tondeur J +1 more

Plain English
This research looked at how to effectively evaluate training programs for teachers in higher education who are using blended learning, which combines traditional classroom methods with online tools. The researchers analyzed 14 studies and found that evaluations can be grouped into five important categories, helping institutions measure the success of their training initiatives more effectively. This is particularly crucial after the shift to online learning caused by the Covid-19 pandemic, ensuring that educators get the support they need to use digital tools well. Who this helps: This helps teachers and educational institutions improve their training programs.

PubMed

Exploring university teachers' online education during COVID-19: Tensions between enthusiasm and stress.

2022

Computers and education open

Bruggeman B, Garone A, Struyven K, Pynoo B, Tondeur J

Plain English
This study looked at how university teachers in Belgium experienced online education during the COVID-19 pandemic. Researchers found that while many teachers felt enthusiastic about the possibilities of online learning, they also faced significant stress due to challenges such as connecting with students and colleagues, managing time pressures, and adapting their teaching roles. Understanding these experiences can help improve future online education for both teachers and students. Who this helps: This helps university teachers and education administrators.

PubMed

Real-World Screening for Retinopathy in Youth With Type 1 Diabetes Using a Nonmydriatic Fundus Camera.

2021

Diabetes spectrum : a publication of the American Diabetes Association

Zimmerman C, Bruggeman B, LaPorte A, Kaushal S, Stalvey M +7 more

Plain English
This study looked at how effective a portable camera is for screening eye damage in young people with type 1 diabetes. Out of 500 participants aged 9 to 26, only 10 cases of diabetic retinopathy (DR) were found, which means about 2% had this eye condition. The findings are important because they show that young people with diabetes who have had the disease for more than 10 years are at a higher risk for eye damage, and using a portable camera for screening can work well in various settings. Who this helps: This benefits young patients with type 1 diabetes and their healthcare providers.

PubMed

Barriers to retinopathy screening in youth and young adults with type 1 diabetes.

2021

Pediatric diabetes

Bruggeman B, Zimmerman C, LaPorte A, Stalvey M, Filipp SL +3 more

Plain English
This study looked at why young people with type 1 diabetes aren’t getting regular eye exams to check for diabetic retinopathy, a condition that can harm their vision. Out of 271 participants aged 10 to 26, 41.7% faced barriers to screening, primarily missing school or work. Only 62.1% had an eye exam in the past year, highlighting a critical gap in care for those most at risk, such as older patients and those with longer diabetes duration. Who this helps: This benefits young patients with type 1 diabetes who need better access to eye care.

PubMed

Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.

2021

Diabetes

Lin A, Mack JA, Bruggeman B, Jacobsen LM, Posgai AL +9 more

Plain English
This study looked at the long-term effects of a treatment using low-dose antithymocyte globulin (ATG) and granulocyte colony-stimulating factor (GCSF) in people who have type 1 diabetes for five years. Researchers found no significant differences in the ability to produce insulin, measured by C-peptide levels, between those who received the treatment and those who did not, indicating that the therapy did not perform better than a placebo. However, a subset of participants who did respond to the treatment maintained stable blood sugar control over the five years. Who this helps: This research benefits patients with type 1 diabetes seeking new treatment options to manage their condition.

PubMed

Addressing health disparities in type 1 diabetes through peer mentorship.

2020

Pediatric diabetes

Walker AF, Haller MJ, Gurka MJ, Morris HL, Bruggeman B +4 more

Plain English
This study looked at how a mentoring program could help teenagers with type 1 diabetes from low-income backgrounds improve their health and outlook. The program paired college students with these teens and provided support like text reminders and social events. While the change in blood sugar levels (HbA1c) was small for both groups, teens in the mentoring program were more hopeful about their futures and attended clinic visits more often. Who this helps: This helps teenagers with type 1 diabetes from underserved communities.

PubMed

An Iterative Process for Identifying Pediatric Patients With Type 1 Diabetes: Retrospective Observational Study.

2020

JMIR medical informatics

Morris HL, Donahoo WT, Bruggeman B, Zimmerman C, Hiers P +2 more

Plain English
This study focused on improving the way doctors identify children with Type 1 diabetes (T1DM) compared to Type 2 diabetes (T2DM). Researchers developed a new automated method that accurately identified 128 children with T1DM out of 295 health records reviewed, achieving a very high accuracy rate of 94.7%. This matters because it can save time and money in finding the right patients for future diabetes research and treatment. Who this helps: This helps pediatricians and researchers working with children with diabetes.

PubMed

Exocrine Pancreas Dysfunction in Type 1 Diabetes.

2020

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Foster TP, Bruggeman B, Campbell-Thompson M, Atkinson MA, Haller MJ +1 more

Plain English
Researchers studied the impact of the exocrine pancreas, which aids in digestion, in people with type 1 diabetes (T1D). They found that T1D patients often have a smaller pancreas and signs of damage like fibrosis and fatty infiltration, with pancreatic exocrine insufficiency (PEI) being more common in these patients compared to those without diabetes. Although many people with T1D have PEI and feel fine, those who do experience symptoms can benefit from treatment, leading to less digestive discomfort, better blood sugar control, and improved overall health. Who this helps: Patients with type 1 diabetes who have digestive issues.

PubMed

Phylogenetic, expression, and functional analyses of anoctamin homologs in Caenorhabditis elegans.

2013

American journal of physiology. Regulatory, integrative and comparative physiology

Wang Y, Alam T, Hill-Harfe K, Lopez AJ, Leung CK +5 more

Plain English
This study looked at a group of proteins called anoctamins in a small worm called Caenorhabditis elegans to understand their roles in the nervous system and how they might influence sensory functions. The researchers found that two specific anoctamins, ANOH-1 and ANOH-2, are present in the worms, with ANOH-1 playing a key role in helping the worms sense and respond to changes in their environment, while losing ANOH-2 didn't seem to affect their behavior. These findings reveal that some functions of the anoctamin family have been around for a long time and may be important for how animals sense their surroundings. Who this helps: This helps researchers studying sensory processes in both invertebrates and vertebrates.

PubMed

Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two dutch families with familial neurohypophyseal diabetes insipidus.

2000

Clinical chemistry

Abbes AP, Bruggeman B, van Den Akker EL, de Groot MR, Franken AA +2 more

PubMed

Frequent Co-Authors

Laura M Jacobsen Desmond A Schatz Michael J Haller Matthew J Gurka Mark A Atkinson Chelsea Zimmerman Timothy P Foster Clayton E Mathews Todd M Brusko Anja Garone

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.